Dawn Traders

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• LACKS FIRM1 refused line

  Manufacturer name and address missing

  The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.

• LACKS N/C1 refused line

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNSAFE ADD1 refused line

  Food additive unsafe under section 409

  The product appeared to contain a food additive that is unsafe within the meaning of section 409 of the FD&C Act, the section that governs which food additives may be used and under what conditions.

• VETDRUGRES1 refused line

  Animal drug residue

  The product appeared to contain a new animal drug, or a conversion product of one, that is unsafe within the meaning of section 512 of the FD&C Act.

Questions about Dawn Traders

Is Dawn Traders on an FDA import alert?

Yes. As of October 26, 2026, Dawn Traders is on the red list of FDA Import Alert 36-04, “Honey and blended syrup: drug residues”, for honey; FDA published the listing on June 23, 2022.

Has FDA refused shipments from Dawn Traders?

Yes. FDA refused 1 shipment line from Dawn Traders on August 10, 2023. The most recent, on August 10, 2023, was honey, charged as UNSAFE ADD (food additive unsafe under section 409).

Why did FDA refuse Dawn Traders's shipments?

The most frequent charges are LACKS FIRM (manufacturer name and address missing, 1 line) and LACKS N/C (net quantity statement missing, 1 line).

What is Dawn Traders's FEI number?

Dawn Traders's FDA Establishment Identifier (FEI) is 3015330518.

Can shipments from Dawn Traders still enter the U.S.?

Shipments of honey from Dawn Traders can be detained without physical examination under Import Alert 36-04; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).